Evidence map›Paper›PMID 29218249›Full record

ArticleAmerican journal of cancer research2017

Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Janet C Reid, Admire Matsika, Claire M Davies, Yaowu He, Amy Broomfield, Nigel C Bennett, Viktor Magdolen, Bhuvana Srinivasan, Judith A Clements, John D Hooper

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Drug Discovery Strategies for Kallikrein-Related Peptidases.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Frontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Janet C ReidMater Research Institute-University of Queensland, Translational Research InstituteWoolloongabba, Queensland 4102, Australia.
Admire MatsikaMater Health ServicesSouth Brisbane, Queensland 4101, Australia.
Claire M DaviesMater Research Institute-University of Queensland, Translational Research InstituteWoolloongabba, Queensland 4102, Australia.
Yaowu HeMater Research Institute-University of Queensland, Translational Research InstituteWoolloongabba, Queensland 4102, Australia.
Amy BroomfieldMater Health ServicesSouth Brisbane, Queensland 4101, Australia.
Nigel C BennettInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of TechnologyWoolloongabba, Queensland 4102, Australia.
Viktor MagdolenClinical Research Unit, Department of Obstetrics and Gynecology, Technical University of MunichIsmaninger Str. 22, D-81675, Germany.
Bhuvana SrinivasanMater Research Institute-University of Queensland, Translational Research InstituteWoolloongabba, Queensland 4102, Australia.
Judith A ClementsInstitute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of TechnologyWoolloongabba, Queensland 4102, Australia.
John D HooperMater Research Institute-University of Queensland, Translational Research InstituteWoolloongabba, Queensland 4102, Australia.
Translational Research Institute · AUMater Health Services · AUTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We provide evidence of a pericellular network of proteases that are elevated and co-expressed in prostate cancer. The network involves the membrane bound serine proteases hepsin and TMPRSS2, the secreted kallikrein-related peptidases KLK4 and KLK14, and the secreted matrix metalloproteinases MMP-3 and MMP-9. Western blot analysis of cell lysates, conditioned cell culture media, immunoprecipitates and cell surface proteins, demonstrates a network of interactions centred largely at the plasma membrane, with the Arg/Lys specific proteases hepsin and TMPRSS2 key regulators of the network. Our data demonstrate that like TMPRSS2, hepsin is able to autoactivate. Active hepsin degrades KLK4, generating a cell associated degradation product with corresponding reduction in levels of cell-free KLK4. In contrast hepsin activates KLK14. TMPRSS2 appears to cleave amino terminal to the KLK4 activation site such that it is available for further processing to generate the active KLK4 protease. In contrast with hepsin, TMPRSS2 degrades KLK14. In addition to these direct mechanisms of regulation, hepsin and TMPRSS2 indirectly modulate KLK4 activity by cleaving the KLK4-activating protease MMP-3. Hepsin and TMPRSS2 also activate MMP-9, which similar to MMP-3, associates with the cell surface. Interestingly our data also show that proteolysis occurs between the membrane spanning and catalytic domains of hepsin and TMPRSS2. Hepsin cleavage occurs via an autoproteolytic mechanism, whereas TMPRSS2 cleavage is mediated by KLK14. Hepsin and TMPRSS2 are not shed from the cell surface but proteolysis likely disrupts domains that regulate the proteolytic activity of these proteases. Immunocytochemical analyses demonstrate that hepsin and TMPRSS2 colocalize on the cell surface with the secreted serine proteases KLK4 and KLK14, only in membrane protrusions, suggesting that reciprocal proteolytic interactions occur in defined cellular structures that are important during cancer dissemination for cell migration, invasion and survival. Also of note, immunohistochemical analysis of serial sections of prostate tumor demonstrated significant overlapping expression of the six proteases

Indexed as

kallikreinmatrix metalloproteinasepericellularProstate cancerserine protease

Identifiers

PMID29218249
PMCPMC5714754
OpenAlexW2784465601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.